MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹3,622 Cr | ₹3,020 Cr | ₹2,515 Cr | ₹1,902 Cr | ₹1,991 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹3,622 Cr |
| Mar2025 | ₹3,020 Cr |
| Mar2024 | ₹2,515 Cr |
| Mar2023 | ₹1,902 Cr |
| Mar2022 | ₹1,991 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,622 Cr | 19.93 | |
| Mar2025 | ₹3,020 Cr | 20.09 | |
| Mar2024 | ₹2,515 Cr | 32.24 | |
| Mar2023 | ₹1,902 Cr | -4.45 | |
| Mar2022 | ₹1,991 Cr | - | |
Compare Operating Profit of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹97,963.6 Cr | -1.2% | -7.2% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.2% |
-7.2% |
-3.5% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses